If a medication is available in the US but not in your country — read When conventional access fails.

Step 1 — You submit a request

A patient, a family member, or the treating physician submits a request indicating the drug name, the indication, the destination country, and basic patient information. Requests can be submitted via our website form, by email, or by direct physician outreach.

Step 2 — Clinical & regulatory review

Our clinical team reviews the request to confirm: (a) the drug is FDA-approved and available through US wholesaler channels; (b) the destination country has an established Named Patient Program or personal-import pathway; (c) the patient has, or can obtain, a prescription from a licensed physician in their country; and (d) the indication is clinically appropriate.

Step 3 — Eligibility & pricing

We respond with eligibility confirmation, the specific destination-country pathway we will use, documentation required from the prescribing physician, expected pricing, and an estimated timeline. Patients can ask questions or cancel at any point before payment.

Step 4 — Physician authorization

The patient's treating physician provides: the prescription, a clinical justification (required in most NPP pathways), and any destination-country forms. We help the physician prepare these documents; we do not replace the physician.

Step 5 — Regulatory filing (where required)

For destination countries requiring MoH or regulator-level approval, we coordinate the filing with the physician and patient. This step may take days to weeks depending on country.

Step 6 — Prepayment

Patients prepay for the drug. This is the industry standard for NPP and keeps the pathway transparent. We never place an order until payment clears.

Step 7 — Sourcing & serialization

We procure the drug from a DSCSA-compliant US specialty wholesaler. Every unit is serialized. The chain-of-custody is digitally recorded from wholesaler to destination.

Step 8 — Cold-chain shipping

We ship via specialized cold-chain carriers to the destination address, typically the patient's treating physician or a hospital pharmacy. We monitor the shipment in real time.

Step 9 — Delivery & follow-up

On delivery, the receiving physician confirms receipt and storage. For drugs requiring administration, the physician oversees. We follow up within 48 hours to confirm safe receipt.

Step 10 — Adverse event reporting

We operate pharmacovigilance workflows. If a patient experiences any adverse event, the treating physician should report to us and we will support reporting to the drug manufacturer and relevant regulators.